# Amneal Pharmaceuticals, Inc.: filings

AMRX · Nasdaq · CIK 1723128 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/amrx.md) · [Financials](/companies/amrx/financials.md) · [Filings](/companies/amrx/filings.md) · [Insiders](/companies/amrx/insiders.md)

## Reports and events: 189 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 309, 8-K 93, 144 37, 3 37, 10-Q 26, SC 13D/A 23, SC 13G/A 22, DEFA14A 17, 8-K/A 10, 10-K 9, SCHEDULE 13D/A 9, DEF 14A 8, SC 13G 8, 424B3 7, SC 13D 7, CORRESP 6, EFFECT 6, UPLOAD 6, 4/A 4, POS AM 4, S-3ASR 4, S-4/A 4, POSASR 3, S-8 3, S-8 POS 3, SCHEDULE 13G/A 3, 8-A12B 2, CERT 2, S-1 2, S-1/A 2, SCHEDULE 13G 2, 144/A 1, 15-12G 1, 25 1, 25-NSE 1, 424B7 1, 5 1, 8-K12B 1, DEF 14C 1, DEFM14A 1, PRE 14A 1, PRE 14C 1, PREM14A 1, RW 1, S-4 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 16:05 ET | [8-K/A](/filings/0001140361-26-040656.md) | 9.01 Financial statements and exhibits | 0001140361-26-040656 |
| 2026-08-12 | 18:05 ET | [SCHEDULE 13D/A](/filings/0000898432-26-000654.md) | Ownership report, active investor, amended | 0000898432-26-000654 |
| 2026-08-12 | 18:04 ET | [SCHEDULE 13D/A](/filings/0000898432-26-000653.md) | Ownership report, active investor, amended | 0000898432-26-000653 |
| 2026-08-12 | 18:01 ET | [SCHEDULE 13D/A](/filings/0000898432-26-000652.md) | Ownership report, active investor, amended | 0000898432-26-000652 |
| 2026-08-10 | 16:05 ET | [8-K](/filings/0001140361-26-032014.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-032014 |
| 2026-08-06 | 17:19 ET | [10-Q](/filings/0001723128-26-000031.md) | Quarterly report, period 2026-06-30 | 0001723128-26-000031 |
| 2026-08-03 | 16:28 ET | [8-K](/filings/0001628280-26-051900.md) | 1.01 Entry into a material agreement | 0001628280-26-051900 |
| 2026-07-31 | 16:08 ET | [8-K](/filings/0001140361-26-030491.md) | 5.07 Shareholder vote results | 0001140361-26-030491 |
| 2026-07-30 | 06:15 ET | [8-K](/filings/0001723128-26-000025.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-26-000025 |
| 2026-05-07 | 16:22 ET | [10-Q](/filings/0001723128-26-000020.md) | Quarterly report, period 2026-03-31 | 0001723128-26-000020 |
| 2026-05-07 | 16:15 ET | [8-K](/filings/0001628280-26-032137.md) | 5.07 Shareholder vote results | 0001628280-26-032137 |
| 2026-05-07 | 16:09 ET | [8-K](/filings/0001723128-26-000019.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001723128-26-000019 |
| 2026-04-22 | 06:22 ET | [8-K](/filings/0001193125-26-168231.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-168231 |
| 2026-03-26 | 18:23 ET | [SCHEDULE 13D/A](/filings/0000898432-26-000204.md) | Ownership report, active investor, amended | 0000898432-26-000204 |
| 2026-03-25 | 16:15 ET | [DEF 14A](/filings/0001308179-26-000143.md) | Proxy statement, period 2026-05-06 | 0001308179-26-000143 |
| 2026-02-27 | 16:19 ET | [10-K](/filings/0001723128-26-000011.md) | Annual report, period 2025-12-31 | 0001723128-26-000011 |
| 2026-02-27 | 06:16 ET | [8-K](/filings/0001723128-26-000008.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-26-000008 |
| 2026-02-03 | 18:36 ET | [8-K](/filings/0001628280-26-004738.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001628280-26-004738 |
| 2026-01-28 | 16:16 ET | [8-K](/filings/0001628280-26-003842.md) | 8.01 Other events | 0001628280-26-003842 |
| 2026-01-13 | 07:44 ET | [8-K](/filings/0001723128-26-000003.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001723128-26-000003 |
| 2025-11-06 | 16:16 ET | [10-Q](/filings/0001723128-25-000062.md) | Quarterly report, period 2025-09-30 | 0001723128-25-000062 |
| 2025-10-30 | 06:19 ET | [8-K](/filings/0001723128-25-000059.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-25-000059 |
| 2025-10-07 | 19:51 ET | [SCHEDULE 13D/A](/filings/0000898432-25-000809.md) | Ownership report, active investor, amended | 0000898432-25-000809 |
| 2025-10-06 | 15:05 ET | [SCHEDULE 13D/A](/filings/0000898432-25-000785.md) | Ownership report, active investor, amended | 0000898432-25-000785 |
| 2025-08-08 | 21:38 ET | [SCHEDULE 13D/A](/filings/0000898432-25-000584.md) | Ownership report, active investor, amended | 0000898432-25-000584 |
| 2025-08-07 | 16:10 ET | [10-Q](/filings/0001723128-25-000047.md) | Quarterly report, period 2025-06-30 | 0001723128-25-000047 |
| 2025-08-05 | 16:39 ET | [8-K/A](/filings/0001723128-25-000040.md) | 5.07 Shareholder vote results | 0001723128-25-000040 |
| 2025-08-05 | 06:15 ET | [8-K](/filings/0001723128-25-000037.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-25-000037 |
| 2025-08-01 | 16:25 ET | [8-K](/filings/0000950103-25-009701.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950103-25-009701 |
| 2025-07-24 | 17:20 ET | [8-K](/filings/0000950103-25-009253.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-25-009253 |
| 2025-07-21 | 07:45 ET | [8-K](/filings/0000950103-25-009025.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-25-009025 |
| 2025-07-21 | 07:41 ET | [8-K](/filings/0001723128-25-000033.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-25-000033 |
| 2025-05-08 | 16:21 ET | [8-K](/filings/0001723128-25-000024.md) | 5.07 Shareholder vote results | 0001723128-25-000024 |
| 2025-05-07 | 16:39 ET | [10-Q](/filings/0001723128-25-000022.md) | Quarterly report, period 2025-03-31 | 0001723128-25-000022 |
| 2025-05-02 | 06:18 ET | [8-K](/filings/0001723128-25-000018.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-25-000018 |
| 2025-03-25 | 16:15 ET | [DEF 14A](/filings/0001308179-25-000220.md) | Proxy statement, period 2025-05-06 | 0001308179-25-000220 |
| 2025-03-17 | 16:45 ET | [SCHEDULE 13D/A](/filings/0000898432-25-000189.md) | Ownership report, active investor, amended | 0000898432-25-000189 |
| 2025-03-06 | 16:16 ET | [8-K](/filings/0001723128-25-000014.md) | 5.02 Departure or appointment of officers or directors | 0001723128-25-000014 |
| 2025-02-28 | 16:53 ET | [10-K](/filings/0001723128-25-000012.md) | Annual report, period 2024-12-31 | 0001723128-25-000012 |
| 2025-02-28 | 06:13 ET | [8-K](/filings/0001723128-25-000009.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-25-000009 |
| 2025-01-23 | 17:49 ET | [SCHEDULE 13D/A](/filings/0000898432-25-000062.md) | Ownership report, active investor, amended | 0000898432-25-000062 |
| 2025-01-15 | 06:14 ET | [8-K](/filings/0001723128-25-000005.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001723128-25-000005 |
| 2024-11-12 | 16:25 ET | [8-K/A](/filings/0001723128-24-000044.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-24-000044 |
| 2024-11-12 | 16:17 ET | [10-Q](/filings/0001723128-24-000042.md) | Quarterly report, period 2024-09-30 | 0001723128-24-000042 |
| 2024-11-08 | 06:08 ET | [8-K](/filings/0001723128-24-000037.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-24-000037 |
| 2024-10-31 | 18:51 ET | [SC 13D/A](/filings/0000898432-24-000861.md) | Ownership report, active investor, amended | 0000898432-24-000861 |
| 2024-10-01 | 07:10 ET | [8-K](/filings/0001628280-24-041646.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-041646 |
| 2024-08-09 | 16:27 ET | [10-Q](/filings/0001723128-24-000032.md) | Quarterly report, period 2024-06-30 | 0001723128-24-000032 |
| 2024-08-09 | 06:14 ET | [8-K](/filings/0001723128-24-000030.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001723128-24-000030 |
| 2024-05-13 | 16:15 ET | [SC 13D/A](/filings/0000898432-24-000401.md) | Ownership report, active investor, amended | 0000898432-24-000401 |

Page 1 of 4. [Older](/companies/amrx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.